These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 18639281

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.
    Kim WJ, Kim EJ, Jeong P, Quan C, Kim J, Li QL, Yang JO, Ito Y, Bae SC.
    Cancer Res; 2005 Oct 15; 65(20):9347-54. PubMed ID: 16230397
    [Abstract] [Full Text] [Related]

  • 3. RUNX3 methylation as a predictor for disease progression in patients with non-muscle-invasive bladder cancer.
    Yan C, Kim YW, Ha YS, Kim IY, Kim YJ, Yun SJ, Moon SK, Bae SC, Kim WJ.
    J Surg Oncol; 2012 Mar 15; 105(4):425-30. PubMed ID: 22311819
    [Abstract] [Full Text] [Related]

  • 4. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y, Tong D, Lou G, Zhang Y, Geng J.
    Pathobiology; 2008 Mar 15; 75(4):244-51. PubMed ID: 18580070
    [Abstract] [Full Text] [Related]

  • 5. RUNX3 methylation and the potential to predict the behavior of bladder cancer.
    Knapp DW.
    J Urol; 2008 Sep 15; 180(3):806-7. PubMed ID: 18635238
    [No Abstract] [Full Text] [Related]

  • 6. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N, Tamura G, Oizumi H, Kanauchi N, Endoh M, Sadahiro M, Motoyama T.
    Lung Cancer; 2007 Oct 15; 58(1):131-8. PubMed ID: 17606310
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Runt-related transcription factor 3 methylation as a possible prognosticator in muscle-invasive bladder cancer.
    Jeong P, Ha YS, Kim JS, Cho IC, Kim WT, Kim YJ, Yi Kim I, Yun SJ, Lee SC, Cha EJ, Kim WJ.
    Cancer Biomark; 2011 Oct 15; 10(5):205-11. PubMed ID: 22699781
    [Abstract] [Full Text] [Related]

  • 9. RUNX3 methylation in normal surrounding urothelium of patients with non-muscle-invasive bladder cancer: potential role in the prediction of tumor progression.
    Jeong P, Min BD, Ha YS, Song PH, Kim IY, Ryu KH, Kim JH, Yun SJ, Kim WJ.
    Eur J Surg Oncol; 2012 Nov 15; 38(11):1095-100. PubMed ID: 22884471
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non-muscle-invasive bladder cancer.
    Kim EJ, Lee YS, Kim YJ, Kim MJ, Ha YS, Jeong P, Lee OJ, Kim WJ.
    Urology; 2010 Jun 15; 75(6):1516.e9-13. PubMed ID: 19913893
    [Abstract] [Full Text] [Related]

  • 12. Epigenetic inactivation of the RUNX3 gene in lung cancer.
    Sato K, Tomizawa Y, Iijima H, Saito R, Ishizuka T, Nakajima T, Mori M.
    Oncol Rep; 2006 Jan 15; 15(1):129-35. PubMed ID: 16328045
    [Abstract] [Full Text] [Related]

  • 13. Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma.
    Long C, Yin B, Lu Q, Zhou X, Hu J, Yang Y, Yu F, Yuan Y.
    Cancer Invest; 2007 Dec 15; 25(8):685-90. PubMed ID: 18058463
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progression.
    Subramaniam MM, Chan JY, Soong R, Ito K, Ito Y, Yeoh KG, Salto-Tellez M, Putti TC.
    Breast Cancer Res Treat; 2009 Jan 15; 113(1):113-21. PubMed ID: 18256927
    [Abstract] [Full Text] [Related]

  • 16. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma.
    Mori T, Nomoto S, Koshikawa K, Fujii T, Sakai M, Nishikawa Y, Inoue S, Takeda S, Kaneko T, Nakao A.
    Liver Int; 2005 Apr 15; 25(2):380-8. PubMed ID: 15780064
    [Abstract] [Full Text] [Related]

  • 17. [Promoter methylation and expression of Runx3 gene in gastric cancer].
    Li LY, Li JK, Shen Y, Yu L, Zhang JH.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul 15; 11(4):379-82. PubMed ID: 18636364
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Promoter hypermethylation identifies progression risk in bladder cancer.
    Yates DR, Rehman I, Abbod MF, Meuth M, Cross SS, Linkens DA, Hamdy FC, Catto JW.
    Clin Cancer Res; 2007 Apr 01; 13(7):2046-53. PubMed ID: 17404085
    [Abstract] [Full Text] [Related]

  • 20. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
    Kim JS, Chae Y, Ha YS, Kim IY, Byun SS, Yun SJ, Kim WJ.
    Clin Genitourin Cancer; 2012 Jun 01; 10(2):114-20. PubMed ID: 22382007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.